FRED KURLAND
CIK 1267273 · CFO · last filed 2023-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.78M
Companies
2
Total Filings
27
Lifetime Open-Market Net
-$200.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. (ARDS) Delisted | CFO | 4,000 | $0.31 | $1.2K | $0 | 7 | 2023-06-15 |
| XOMA | CFO & VP Finance | 114,461 | $41.79 | $4.78M | -$200.5K | 17 | 2015-04-07 |
Recent Filings · Page 3 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-23 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2011-10-28 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2011-03-28 | XOMA | Buy (P) | +5,000 | $16.3K | EDGAR |
| 2011-01-11 | XOMA | Grant (A) | — | $0 | EDGAR |
| 2010-03-03 | — | Grant (A) | — | $0 | |
| 2009-03-02 | — | Grant (A) | — | $0 | |
| 2009-01-02 | — | Grant (A) | — | $0 |
Showing 21–27 of 27
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.